Merck Says Study Shows COVID-19 Drug Causes Quick Reduction in Virus

US News 6-3-2021 U.S. News 12
(Reuters) - U.S. drugmaker Merck & Co Inc said on Saturday the experimental antiviral drug molnupiravir it is developing with Ridgeback Bio... 
Read The Rest at U.S. News- (opens a new tab)





Pages

Archive